
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 639-648.DOI: 10.12114/j.issn.1007-9572.2024.0295
Special Issue: 阿尔茨海默病最新文章合辑; 中医最新文章合辑; 社区失智症管理最新文章合辑; 神经/行为/心理最新文章合辑
• Review & Perspectives • Previous Articles
Received:2024-07-10
Revised:2024-08-25
Published:2025-02-15
Online:2024-11-25
Contact:
LIU Bin
通讯作者:
刘斌
作者简介:作者贡献:
裴金英提出研究命题,进行文章的构思与撰写;宋金洲、马到丰进行文献的检索与收集;罗孝廷、董晓红、丛树园进行论文修订;刘斌负责文章的质量控制及审校,并对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0295
| 有效成分 | 模型 | 剂量 | 靶点 |
|---|---|---|---|
| 红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
| Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
| 连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
| 芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
| 淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
| 何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
| 远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
| 细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
| 银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
| Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
| 小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
| 番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
| 旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
| 圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
| 表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
| 仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
| 大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
| 麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
| 茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
Table 1 Experimental study on the treatment of Alzheimer's disease with effective ingredients of traditional Chinese medicine
| 有效成分 | 模型 | 剂量 | 靶点 |
|---|---|---|---|
| 红景天苷 | SAMP8小鼠 | 30 mg/kg | Aβ1-42、铁沉积、MDA、IL-1β、IFN-γ、TNF-α、ACSL4、TFR1↓、GSH、SOD、IL-10、GPX4、SLC7A11、SLC3A2、FTH1、Fpn1、Nrf2、HO-1↑ |
| Nrf2基因敲除小鼠、C57BL/6小鼠 | 50 mg/kg | MDA↓、SOD↑、GSH/GSSG↑、GPX4↑、SLC7A11↑、HO-1↑、ROS↓、Nrf2↑、Fe2+↓、PTGS2↓ | |
| 连翘酯苷A | APP/PS1小鼠 | 30 mg/kg | MDA↓、MMP,Aβ1-42、p-tau、NO↓、IL-4↑、IL-10↑、IL-1β↓、IL-6↓、Fe、GPX4↑、xCT↑、FTL↑、Fpn↑、DRD1↑、CREB↑、BDNF↑、TrkB↑、PI3K、p-AKT、GNAL↑、Adcy5↑、cAMP↑、p-Fyn↓、p-GSK-3β↑、Nrf2↑、TFRC↓、DMT1↓、FTH↑、Iba1↓、GFAP↓、TGF-β↑、MCP-1↓、ALOX5↓、CD33↓、iNOS↓、TNF-α↓、IKK↓ |
| 芍药苷 | C57BL/6小鼠、APP/PS1小鼠 | 10 mg/kg | Fe3+↓、SOD↑、MDA↓、JC-1↑、P53↓、STAT3、GPX4↑、GAPDH、ΔΨm |
| 淫羊藿苷 | APP/PS1小鼠、C57BL/6小鼠 | 5、10 mg/kg | MDA↓、SOD↑、MDM2、GSH-Px↑、LDH↓、GSH↑、caspase-3↓、Fe↓、p53↓、Aβ25-35↓、p-Tau |
| 何首乌苷 | APP/PS1小鼠、C57BL/6小鼠 | 60、120、180 mg/kg | Aβ↓、GSS、SOD1、SOD2、Prdx1、8-OHdG↓、Nrf2↑、Keap1↑、HO-1↑、NQO1↑、GCLC↑、GCLM↑、NLRP3↓、TXNIP↓、TXNRD1↓、iNOS↓、GPX4↑、xCT、GPX4↑、GPX1↑、FTH1↑、xCT↑、CD98↑、DMT1↓、ACSL4↓、NCOA4↓、FTH↓、FTL↓ |
| 远志皂苷元 | Aβ25-35诱导的PC12细胞 | 15、30、60、120、240 μmol/L | ACSL4↓、PEBP1↓、GPX4↑、ROS↓、MDA、GAPDH |
| 细叶远志皂苷 | C57BL/6小鼠 | 10 mg/kg | AKT、STAT3、CASP3、BDNF↑、PSD95↑、p-TrkB↑、Actin、p-Akt↑、mRNA↑、Ca2+↓、m-calpain↓、calpastatin↑、MDA↓、GSH↑、SOD↑、CAT↑、ROS↓、MFI↓、ACSL4↓、GPX4↑、SLC7A11↑、SYN |
| 银杏内酯B | SAMR1小鼠、SAMP8小鼠 | 20、30、40 mg/kg | GFAP、Iba-1、TNF-a、IL-1b、IL-6、SOD↑、GSH↑、MDA↓、NO↓、ROS↓、GPX4↑、Fe2+↓、TFR1、NCOA4、FTH1↑、Nrf2↑、RSL3、GAPDH、Lamin B1、DAPI |
| Aβ1-42诱导的N2a细胞 | 100 μmol/L | FTH1↑、SPP1↓、ROS↓、SOD↑、MDA↓、SLC7A11↓、Psen2、Fn1↑、Ftl1↑、Syn1↓、Apom↓ | |
| 小檗碱 | 3×Tg-AD小鼠、WT小鼠 | 50 mg/kg | APP↓、Bace1↓、Aβ1-42↓、ADAM10↑、P-tau↓、Fe3+、Fe2+、FTH1、TFR、GSH↑、MDA↓、GPX4↑、SLC7A11↑、ACSL4↓、Nrf2、Keap1、4HNE↓、Fpn1、 |
| 番泻苷A | C57BL/6小鼠、APP/PS1小鼠 | 7.5、15、30 mg/kg | caspase-3↓、PARP-1↓、GSH↑、MDA↓、ROS、IL-1β↓、IL-6↓、TNF-α↓、TRAF6↓、p-P65↓ |
| 旋覆花内酯 | 5xFAD小鼠、C57BL6小鼠 | 20 mg/kg | TNF-α↓、PGE2↓、IL-10↑、Arg-1↑、iNOS↓、COX-2↓、GPx4、GSH↑、MDA↓、T-SOD↓、BACE1↓、Aβ↓、p-Tau↓、GFAP↓、Iba-1↓ |
| 圣草酚 | APP/PS1小鼠 | 50 mg/kg | Aβ↓、p-Tau↓、TfRC↓、FTH↓、Fpn↑、MDA↓、GPX4↑、ROS、mRNA↑、p-Nrf2↑、VDR、HO-1↑ |
| 表没食子儿茶素没食子酸酯 | DNL细胞、CHO细胞 | 1~10 μmol/L | TfR↑、β-actin、Aβ↓、holo-APP↓、IRPs、APP、sAPPα↑、mRNA |
| 仙茅苷 | ICR小鼠 | 50、100 mg/kg | GPX4↑、SLC7A11↓、MDA↓、Fe↓、GSH↑、GSH/GSSG↑、GAPDH、GCLM↑、GCLC↑、ROS↓、LIP、Aβ1-42↓、ACSL4↓、p-BECN1↑、p-Tau↓、FPN↑、STEAP3、DMT1 |
| 大黄酚 | SD大鼠(D-半乳糖造模) | 0.036 mg/mL | GPx↑、GSH↑、GPX4↑、ROS↓、GAPDH、Aβ |
| 麝香水提物 | HT22细胞 | 330 μg/mL、60 μg/mL | MDA↓、GSH↑、ROS↓、GPX4↑、SLC7A11↑、TFRC↓、Fpn1↑、FTH1↑、Fe2+、Nrf2、Keap1↓、HO-1、FTH1 |
| 茯苓酸 | SD大鼠(Aβ25-35诱导) | 50 mg/kg | Nrf2、SLC7A11、GPX4↑、GSH↑、MDA↓、Fe2+↓ |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
李燕新,吕占云,李维,等. 铁死亡相关蛋白在AD小鼠海马中的表达[J]. 中国神经精神疾病杂志,2018,44(12):727-731. DOI:10.3969/j.issn.1002-0152.2018.12.008.
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
樊赟,窦润鹏,胡久略,等. 茯苓酸通过Nrf2/SLC7A11/GPX4信号通路调控铁死亡改善阿尔茨海默病大鼠认知障碍的研究[J]. 中国全科医学,2024,27(2):177-183. DOI:10.12114/j.issn.1007-9572.2023.0326.
|
| [79] |
|
| [80] |
刘珊,贺小平,赵炎,等. 淫黄葛合剂对APP/PS1 HAMP-/-小鼠认知功能和铁死亡氨基酸代谢通路的影响[J]. 中国病理生理杂志,2024,40(3):502-510. DOI:10.3969/j.issn.1000-4718.2024.03.014.
|
| [81] |
|
| [1] | LI Jing, LIU Ziqi, QIAN Li, YAO Ruiqin. Research Progress on the Role of the Microbiota-gut-brain Axis in Epilepsy [J]. Chinese General Practice, 2026, 29(32): 4821-4826. |
| [2] | ZHAO Qiyu, LI Xinyue, WU Minmin, CHEN Qiuxin. Regulatory Mechanisms and Targeted Therapeutic Research of Mitochondria in Ferroptosis Following Cerebral Hemorrhage [J]. Chinese General Practice, 2026, 29(32): 4827-4832. |
| [3] | TAN Libo, LIU Nanyang, LI Hao. Evidence Mapping Analysis of Clinical Studies on Treatment of Alzheimer's Disease with Chinese Patent Medicines [J]. Chinese General Practice, 2026, 29(32): 4805-4814. |
| [4] | LI Jiao, XIANG Qingwei, LIU Jinjin, PENG Lang, ZHOU Jianjie, YANG Qiong, MEI Yingbing, LIU Hui, FANG Yingsong, TAN Zihu. Development and Validation of Risk Prediction Model for Fall-related Hospitalization in Patients with Alzheimer's Disease [J]. Chinese General Practice, 2026, 29(32): 4721-4729. |
| [5] | WANG Shiyi, FAN Xiaojing, SI Yafei, ZHOU Zhongliang. Advances in Key Measurement Techniques for the Intrinsic Capacity of Elderly in the Context of Healthy Aging [J]. Chinese General Practice, 2026, 29(31): 4662-4666. |
| [6] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [7] | ZHAO Jiayi, FAN Jian, YU Dehua. The Current Situation, Challenges, and Coping Strategies of Preserving Ratio Impaired Spirometry [J]. Chinese General Practice, 2026, 29(30): 4366-4371. |
| [8] | LI Xiling, ZHANG Fan, YANG Xinyue, YANG Heng. Application of Exercise Snacks in Chronic Disease Management: a Scoping Review [J]. Chinese General Practice, 2026, 29(30): 4472-4479. |
| [9] | LI Jiao, ZHOU Jianjie, PENG Lang, MEI Yingbing, TAN Zihu. Development and Validation of a Risk Prediction Model for Poor Prognosis in Alzheimer's Disease Patients with Community-acquired Pneumonia [J]. Chinese General Practice, 2026, 29(29): 4248-4257. |
| [10] | CHEN Yujing, WANG Yan, LI Guang, DONG Benchao, YANG Peichuan, MA Jianxiong. Digital Technologies in the Management of Sarcopenia among Older Adults in Asia: a Scoping Review [J]. Chinese General Practice, 2026, 29(29): 4200-4210. |
| [11] | XIE Xiaoyun, LIU Chenxi, LIU Yushu, ZHOU Yihan. Artificial Intelligence Research Practices in Primary Healthcare Institutions in China and the Potential Issue of Data Poverty: a Scoping Review [J]. Chinese General Practice, 2026, 29(28): 4067-4077. |
| [12] | FENG Yachen, LIU Lewei, XUE Jinyue, SUN Xianlin, LIU Huanzhong. Research Progress of Wearable Technology in the Diagnosis and Treatment of Mental Disorders [J]. Chinese General Practice, 2026, 29(27): 4016-4025. |
| [13] | LI Haijin, ZHU Chenli, LI Hui, FENG Zhengwen, QIAO Yuchen, DU Juan. Quality Evaluation and Content Analysis of Guidelines Related to Post-diagnosis Management of Dementia [J]. Chinese General Practice, 2026, 29(25): 3569-3576. |
| [14] | LIU Yahui, XU Yanan, YUAN Ling, WU Ligui, ZHOU Yujie, KANG Yubiao. A Scoping Review on Triage for Palliative Care Patients Based on Priority Decision-making [J]. Chinese General Practice, 2026, 29(24): 3538-3544. |
| [15] | WANG Rui, LUO Shuoming, YANG Liang, WANG Peng, ZHAO Yang, WANG Qi, ZHOU Zhiguang. Diabetes Prevalence among Older Adults in China: a Systematic Review and Meta-analysis [J]. Chinese General Practice, 2026, 29(24): 3500-3508. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||